Literature DB >> 20872027

S100A11, a dual growth regulator of epidermal keratinocytes.

Masakiyo Sakaguchi1, Nam-ho Huh.   

Abstract

S100A11, a member of the family of S100 proteins, is a dimmer, each monomer of which has two EF-hands. Expression of S100A11 is ubiquitous in various tissues at different levels, with a high expression level in the skin. We have analyzed functions of S100A11 mainly in normal human keratinocytes (NHK) as a model cell system of human epithelial cells. High Ca(2+) and transforming growth factor-β (TGF-β), two representative growth suppressors for NHK, need a common S100A11-mediated pathway in addition to unique pathways (NFAT1-mediated pathway for high Ca(2+) and Smad-mediated pathway for TGF-β) for exhibiting a growth inhibitory effect. S100A11 has another action point for growth suppression in NHK. Annexin A1 (ANXA1) complexed with S100A11 efficiently binds to and inhibits cytosolic phospholipase A2 (cPLA2), the activity of which is needed for the growth of NHK. On exposure of NHK to epidermal growth factor (EGF), ANXA1 is cleaved at 12Trp, and this truncated ANXA1 loses binding capacity to S100A11, resulting in maintenance of an active state of cPLA2. On the other hand, we found that S100A11 is actively secreted by NHK. Extracellular S100A11 acts on NHK to enhance the production of EGF family proteins, resulting in growth stimulation. These findings indicate that S100A11 plays a dual role in growth regulation, being suppressive in cells and being promotive from outside of cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20872027     DOI: 10.1007/s00726-010-0747-4

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  18 in total

1.  S100A11 plays a role in homologous recombination and genome maintenance by influencing the persistence of RAD51 in DNA repair foci.

Authors:  Franziska Foertsch; Anna Szambowska; Anja Weise; Alexandra Zielinski; Bernhard Schlott; Florian Kraft; Kristin Mrasek; Kerstin Borgmann; Helmut Pospiech; Frank Grosse; Christian Melle
Journal:  Cell Cycle       Date:  2016-08-11       Impact factor: 4.534

2.  Correlation between S100A11 and the TGF-β1/SMAD4 pathway and its effects on the proliferation and apoptosis of pancreatic cancer cell line PANC-1.

Authors:  Yi-Fei Ji; Tao Li; Feng Jiang; Wen-Kai Ni; Cheng-Qi Guan; Zhao-Xiu Liu; Cui-Hua Lu; Run-Zhou Ni; Wei Wu; Ming-Bing Xiao
Journal:  Mol Cell Biochem       Date:  2018-06-19       Impact factor: 3.396

3.  Network-based survival analysis to discover target genes for developing cancer immunotherapies and predicting patient survival.

Authors:  Xinwei He; Xiaoqiang Sun; Yongzhao Shao
Journal:  J Appl Stat       Date:  2020-09-03       Impact factor: 1.416

4.  Active Secretion of Dimerized S100A11 Induced by the Peroxisome in Mesothelioma Cells.

Authors:  Satomi Saho; Hiroki Satoh; Eisaku Kondo; Yusuke Inoue; Akira Yamauchi; Hitoshi Murata; Rie Kinoshita; Ken-Ichi Yamamoto; Junichiro Futami; Endy Widya Putranto; I Made Winarsa Ruma; I Wayan Sumardika; Chen Youyi; Ken Suzawa; Hiromasa Yamamoto; Junichi Soh; Shuta Tomida; Yoshihiko Sakaguchi; Ken Saito; Hidekazu Iioka; Nam-Ho Huh; Shinichi Toyooka; Masakiyo Sakaguchi
Journal:  Cancer Microenviron       Date:  2016-06-22

Review 5.  Joining S100 proteins and migration: for better or for worse, in sickness and in health.

Authors:  Stephane R Gross; Connie Goh Then Sin; Roger Barraclough; Philip S Rudland
Journal:  Cell Mol Life Sci       Date:  2013-06-30       Impact factor: 9.261

6.  Tudor staphylococcal nuclease drives chemoresistance of non-small cell lung carcinoma cells by regulating S100A11.

Authors:  Anna Zagryazhskaya; Olga Surova; Nadeem S Akbar; Giulia Allavena; Katarina Gyuraszova; Irina B Zborovskaya; Elena M Tchevkina; Boris Zhivotovsky
Journal:  Oncotarget       Date:  2015-05-20

7.  Non-Cationic Proteins Are Associated with HIV Neutralizing Activity in Genital Secretions of Female Sex Workers.

Authors:  Kenzie D M Birse; Amy L Cole; Taha Hirbod; Lyle McKinnon; Terry B Ball; Garrett R Westmacott; Joshua Kimani; Frank Plummer; Alexander M Cole; Adam Burgener; Kristina Broliden
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

8.  Knockdown of S100A11 expression suppresses ovarian cancer cell growth and invasion.

Authors:  Youqing Liu; Xiaobing Han; Baoan Gao
Journal:  Exp Ther Med       Date:  2015-02-03       Impact factor: 2.447

9.  Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma.

Authors:  Hiroki Sato; Masakiyo Sakaguchi; Hiromasa Yamamoto; Shuta Tomida; Keisuke Aoe; Kazuhiko Shien; Takahiro Yoshioka; Kei Namba; Hidejiro Torigoe; Junichi Soh; Kazunori Tsukuda; Hiroyuki Tao; Kazunori Okabe; Shinichiro Miyoshi; Harvey I Pass; Shinichi Toyooka
Journal:  Oncogenesis       Date:  2018-01-24       Impact factor: 7.485

10.  S100A11 promotes human pancreatic cancer PANC-1 cell proliferation and is involved in the PI3K/AKT signaling pathway.

Authors:  Mingbing Xiao; Tao Li; Yifei Ji; Feng Jiang; Wenkai Ni; Jing Zhu; Baijun Bao; Cuihua Lu; Runzhou Ni
Journal:  Oncol Lett       Date:  2017-10-31       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.